Vision 2020: eliminating preventable blindness

Article

We speak with Ivo Kocur of the World Health Organization who tells us how Vision 2020 is helping to reduce avoidable blindness in children around the world.

VISION 2020: The Right to Sight is the joint Global Initiative of the WHO and the International Agency for the Prevention of Blindness (IAPB), which includes an international coalition of non-governmental organisations (NGOs), professional associations, eye care institutions and corporations. With help from VISION 2020, these member organizations run projects all around the world to help improve eye care services to those who most need them. For this year's World Sight Day (11th October) the initiative is raising awareness of avoidable blindness in children and this month sees the launch of its "VISION for Children"1 report, which outlines some of the projects that have been making an impact around the world and aims to draw attention to the work that still needs to be done.

Europe is not guilt-free

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.